viaskin peanut
Allergenexperimental
Clinical trial activity
7 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
6
Phase 3
4
Phase 4
0
Earliest trial started Aug 1, 2012 (NCT01675882)
Timeline
Indications
Studied for
Mechanism of action
- Arachis hypogaeaImmunity, desensitized
Arachis hypogaea immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- viaskin peanut
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03211247 | Phase 3 | Jul 31, 2017 | DBV Technologies |
| NCT03013517 | Phase 3 | Jan 1, 2017 | DBV Technologies |
| NCT02916446 | Phase 3 | Oct 1, 2016 | DBV Technologies |
| NCT02636699 | Phase 3 | Dec 1, 2015 | DBV Technologies |
| NCT01955109 | Phase 2 | Sep 1, 2013 | DBV Technologies |
| NCT01675882 | Phase 2 | Aug 1, 2012 | DBV Technologies |
| NCT04371627 | N/A | — | DBV Technologies |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| DBV Technologies | For profit | 7 | 7 | 3 | 2012 |
1 organizations
Page 1 / 1